HEMO-GE.ApS: Financial statements 2022
CVR: 39076322
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
HEMO-GE.ApS (CVR 39076322) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -5,813 and a net result of DKK 124,096 compared with DKK 95,583 the year before. Equity in the 2022 report amounted to DKK 1,999,070. The solvency ratio was 99.8%.
- Gross Profit
- DKK -5,813
- Profit/Loss
- DKK 124,096
- Equity
- DKK 1,999,070
- Total Assets
- DKK 2,003,920
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -6 t. | 124 t. | 2 mio. | - |
| 2021 | - | -4 t. | 96 t. | 2 mio. | - |
| 2020 | - | -4 t. | 96 t. | 2.1 mio. | - |
| 2019 | - | -4 t. | -5 t. | 2.1 mio. | - |
| 2018 | - | -7 t. | 194 t. | 2.2 mio. | - |
Official annual report
Keep an eye on HEMO-GE.ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
HEMO-GE.ApS has published its annual report for 2021. Gross profit came to DKK -4,375, and the net result was DKK 95,583.
About HEMO-GE.ApS
HEMO-GE.ApS is a Danish company of the type Anpartsselskab based in Rudkøbing, founded in 2017. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Henrik Graakjær Eriksen. The company is owned by Henrik Graakjær Eriksen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -6,000 and a net result of DKK 90,958 compared with DKK 96,416 the year before. Equity in the 2025 report amounted to DKK 4,326,266.